Published in Clin Genet on July 01, 2009
Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder. Ann Lab Med (2015) 0.81
The first Korean case of HDR syndrome confirmed by clinical and molecular investigation. Yonsei Med J (2015) 0.75
Clinical description of a neonate carrying the largest reported deletion involving the 10p15.3p13 region. Clin Case Rep (2017) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet (1994) 2.68
Pachydermoperiostosis: an update. Clin Genet (2005) 2.65
Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med (1984) 2.58
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrob Agents Chemother (1988) 2.52
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J (1999) 2.33
Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr (1999) 2.18
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun (1995) 2.06
Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol (1990) 2.02
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338. Antimicrob Agents Chemother (1989) 1.94
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet (1995) 1.82
Comparative in vitro activity of a new quinolone, AM-1091. Antimicrob Agents Chemother (1989) 1.78
In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105. Antimicrob Agents Chemother (1988) 1.75
Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype. Am J Med Genet (1994) 1.73
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg (1987) 1.58
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents Chemother (1988) 1.56
The phenotype of partial dup(7q) reconsidered: a report of five new cases. Clin Genet (1988) 1.54
Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet (2003) 1.53
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.53
Atrioventricular canal defect and postaxial polydactyly indicating phenotypic overlap of Ellis-van Creveld and Kaufman-McKusick syndromes. Pediatr Cardiol (1997) 1.52
Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol (1999) 1.50
Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet (1992) 1.50
Two high throughput technologies to detect segmental aneuploidies identify new Williams-Beuren syndrome patients with atypical deletions. J Med Genet (2005) 1.48
NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47
Linkage relationships between Retinoschisis, Xg, and a cloned DNA sequence from the distal short arm of the X chromosome. Hum Genet (1983) 1.47
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Jeune syndrome associated with cystinuria: report of two sisters. Am J Med Genet (1990) 1.43
Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Hum Genet (1989) 1.43
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent. Eur J Clin Microbiol Infect Dis (1988) 1.43
Individual haploinsufficient loci and the complex phenotype of DiGeorge syndrome. Mol Med Today (2000) 1.41
Prenatal diagnosis of triose phosphate isomerase deficiency. Lancet (1989) 1.40
Noonan syndrome with cardiac left-sided obstructive lesions. Hum Genet (1997) 1.39
A locus for autosomal dominant keratoconus maps to human chromosome 3p14-q13. J Med Genet (2004) 1.36
Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet (2004) 1.35
[Familial translocation 2-D]. Ann Genet (1968) 1.35
Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes. J Med Genet (1999) 1.35
Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32
Familial deletions of chromosome 22q11. Am J Med Genet (1997) 1.29
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. Eur J Clin Microbiol Infect Dis (1989) 1.28
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet (1999) 1.24
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 1.23
Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli. Amino Acids (2006) 1.21
Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am J Hum Genet (1999) 1.21
Chemistry and mode of action of macrolides. J Antimicrob Chemother (1993) 1.18
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure (2000) 1.16
UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet (1997) 1.13
New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle. Clin Genet (2010) 1.12
Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet (2007) 1.10
Interstitial deletion 13q syndromes: a report on two unrelated patients. Hum Genet (1979) 1.10
Congenital heart defects in Kabuki syndrome. Am J Med Genet (2001) 1.09
Adverse effects of macrolide antibacterials. Drug Saf (1993) 1.09
The effects of telencephalic pallial lesions on spatial, temporal, and emotional learning in goldfish. Brain Res Bull (2002) 1.09
Meiotic drive at the myotonic dystrophy locus. J Med Genet (1994) 1.08
Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation (2001) 1.08
Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview. Am J Med Genet (1985) 1.08
The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology (2005) 1.08
RASopathies: Clinical Diagnosis in the First Year of Life. Mol Syndromol (2011) 1.07
Chromosomal microarray as first-tier approach in low-risk pregnancies: detection rate should not be the only criterion for its application. Ultrasound Obstet Gynecol (2014) 1.07
Discharge characteristics of medial rectus and abducens motoneurons in the goldfish. J Neurophysiol (1991) 1.07
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Drugs (1983) 1.06
Cardiac malformations in patients with oral-facial-skeletal syndromes: clinical similarities with heterotaxia. Am J Med Genet (1999) 1.06
The clinical utility and indications of chromosomal microarray analysis in prenatal diagnosis. BJOG (2013) 1.06
Transplacental transmission of human polyomavirus BK. J Med Virol (1998) 1.06
Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol (1999) 1.06
Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. J Exp Med (1987) 1.05
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res (1997) 1.05
Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy. J Clin Invest (1994) 1.05
Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J Neurochem (2001) 1.04
Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol (2001) 1.04